Vontobel Asset Management Inc Edwards Lifesciences Corp Transaction History

Vontobel Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $6.98 Million - $7.99 Million	-97,286 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $4.14 Million - $5.07 Million	-67,204 Reduced 40.86%	97,286 $22.8 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $1.09 Million - $1.26 Million	19,519 Added 13.46%	164,490 $30.4 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $195,678 - $261,708	4,086 Added 2.9%	144,971 $27.7 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $818,208 - $1 Million	17,630 Added 14.3%	140,885 $21.6 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $463,215 - $588,192	10,136 Added 8.96%	123,255 $21.5 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $284,627 - $343,966	-6,705 Reduced 5.6%	113,119 $16.5 Million
Q1 2018 Apr 09, 2018	SELL	$37.19 - $47.45 $2.33 Million - $2.97 Million	-62,636 Reduced 34.33%	119,824 $16.7 Million
Q4 2017 Jan 16, 2018	BUY	$33.79 - $39.39 $6.17 Million - $7.19 Million	182,460	182,460 $20.6 Million

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Vontobel Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Vontobel Asset Management Inc with notifications on news.